{
    "organizations": [],
    "uuid": "cd7362875ae1eaccd5a87f95379bafaf8584d774",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fate-therapeutics-q4-loss-per-shar/brief-fate-therapeutics-q4-loss-per-share-0-29-idUSASB0C8U8",
    "ord_in_thread": 0,
    "title": "BRIEF-Fate Therapeutics Q4 Loss Per Share $0.29​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Fate Therapeutics Inc:\n* FATE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS\n* QTRLY ‍LOSS PER SHARE $0.29​ * Q4 EARNINGS PER SHARE VIEW $-0.24 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T05:17:00.000+02:00",
    "crawled": "2018-03-06T22:24:46.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "fate",
        "therapeutic",
        "inc",
        "fate",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "highlight",
        "operational",
        "progress",
        "qtrly",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}